Literature DB >> 23754700

¹H, ¹³C and ¹⁵N backbone and side-chain resonance assignments of the N-terminal ubiquitin-binding domains of USP25.

Li Shi1, Yi Wen, Naixia Zhang.   

Abstract

Ubiquitin Specific Protease 25 (USP25), a member of the deubiquitinase family, is involved in several disease-related signal pathways including myogenesis, immunity and protein degradation. It specially catalyzes the hydrolysis of the K48-linked and K63-linked polyubiquitin chains. USP25 contains one ubiquitin-associated domain and two ubiquitin-interacting motifs (UIMs) in its N-terminal region, which interact with ubiquitin and play a role in substrate recognition. Besides, it has been shown that the catalysis activity of USP25 is either impaired by sumoylation or enhanced by ubiquitination within its UIM. To elucidate the structural basis of the cross-regulation of USP25 function by non-covalent binding and covalent modifications of ubiquitin and SUMO2/3, a systematic structural biology study of USP25 is required. Here, we report the (1)H, (13)C and (15)N backbone and side-chain resonance assignments of the N-terminal ubiquitin binding domains (UBDs) of USP25 with BMRB accession number of 19111, which is the first step of the systematic structural biology study of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23754700     DOI: 10.1007/s12104-013-9495-1

Source DB:  PubMed          Journal:  Biomol NMR Assign        ISSN: 1874-270X            Impact factor:   0.746


  3 in total

1.  LPS promotes HBO1 stability via USP25 to modulate inflammatory gene transcription in THP-1 cells.

Authors:  Chen Long; Yandong Lai; Jin Li; Jiangsheng Huang; Chunbin Zou
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2018-08-04       Impact factor: 4.490

2.  Structural and Functional Investigations of the N-Terminal Ubiquitin Binding Region of Usp25.

Authors:  Yuanyuan Yang; Li Shi; Yiluan Ding; Yanhong Shi; Hong-Yu Hu; Yi Wen; Naixia Zhang
Journal:  Biophys J       Date:  2017-05-23       Impact factor: 4.033

3.  NMR-based platform for fragment-based lead discovery used in screening BRD4-targeted compounds.

Authors:  Jun-Lan Yu; Tian-Tian Chen; Chen Zhou; Fu-Lin Lian; Xu-Long Tang; Yi Wen; Jing-Kang Shen; Ye-Chun Xu; Bing Xiong; Nai-Xia Zhang
Journal:  Acta Pharmacol Sin       Date:  2016-05-30       Impact factor: 6.150

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.